Rosemary Mazanet
Director/Board Member bei ONCTERNAL THERAPEUTICS, INC.
Vermögen: 772 327 $ am 31.03.2024
Profil
Rosemary Mazanet gründete Apelles Investment Management LP. Sie ist Präsidentin von Rosemary Mazanet LLC, Präsidentin von R Mazanet LLC und Chief Scientific Officer für Columbia Care, Inc. Dr. Mazanet ist auch Mitglied des Vorstands von Oncternal Therapeutics, Inc. In ihrer früheren Laufbahn war Dr. Mazanet Chief Executive Officer von Breakthrough Therapeutics LLC, Senior Director-Clinical Research bei Amgen, Inc, Leiterin der Forschung bei Argenis Capital Advisors LLC, Partner bei Apelles Investment Management LP, Venture Partner bei Colt Ventures Ltd, Chief Medical Officer & Executive Vice President bei Galena Biopharma, Inc und Chief Scientific Officer & General Partner bei Oracle Partners LP. Dr. Mazanet erwarb einen Bachelor-Abschluss an der University of Virginia und einen Doktortitel an der Perelman School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.04.2024 | 2 153 869 ( 0,48% ) | 771 085 $ | 31.03.2024 | |
| 28.06.2023 | 138 ( 0,00% ) | 1 242 $ | 31.03.2024 |
Aktive Positionen von Rosemary Mazanet
| Unternehmen | Position | Beginn |
|---|---|---|
| THE CANNABIST COMPANY HOLDINGS INC. | Director/Board Member | 07.09.2023 |
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 27.01.2021 |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Director/Board Member | - |
| R Mazanet LLC | President | 01.05.2004 |
| Rosemary Mazanet LLC | President | - |
| University of Pennsylvania Medical Center | Director/Board Member | - |
Ehemalige bekannte Positionen von Rosemary Mazanet
| Unternehmen | Position | Ende |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Chief Tech/Sci/R&D Officer | 07.11.2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Director/Board Member | 18.04.2013 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Director/Board Member | 18.04.2013 |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Rosemary Mazanet
| University of Virginia | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Perelman School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| AKSYS LTD. | Finance |
| THE CANNABIST COMPANY HOLDINGS INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Diabetes America, Inc.
 Diabetes America, Inc. Medical/Nursing ServicesHealth Services Founded in 2004, Diabetes America has established a reputation in communities across Texas as a comprehensive health center and management program for individuals with diabetes, providing them with a team of physicians, dietitians, and certified diabetes educators all under one roof. Diabetes America's personalized education and lifestyle support provide patients with lifelong guidance for managing their diabetes and gives them the tools and support they need to take charge of their lives. | Health Services |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Amorcyte, Inc.
 Amorcyte, Inc. Miscellaneous Commercial ServicesCommercial Services Amorcyte, Inc. provides cell therapy product development services. It focuses on developing cell therapeutics for cardiovascular disease. The company was founded by Andrew L. Pecora in 2004 and is headquartered in Allendale, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Argenis Capital Advisors LLC
 Argenis Capital Advisors LLC Investment ManagersFinance Argenis Capital Advisors LLC is an independent hedge fund manager headquartered in New York City. Founded in 2006, the firm provides investment advice to high net worth individual and institutional clients. | Finance |
| Oracle Partners LP | |
| Breakthrough Therapeutics LLC | |
Colt Ventures Ltd.
 Colt Ventures Ltd. Investment ManagersFinance Colt Ventures Ltd (Colt Ventures) is a venture capital firm founded in 2003 by Darren Blanton. The firm is headquartered in Dallas, Texas. | Finance |
Apelles Investment Management LP
 Apelles Investment Management LP Investment ManagersFinance Apelles Investment Management LP is a hedge fund manager located in New York Cit | Finance |
| Rosemary Mazanet LLC | |
| R Mazanet LLC | |
Oncolyze, Inc.
Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Health Technology |
